Usana's FCPA probe costs rise
Two companies facing foreign bribery probes tied to operations in China, Misonix and Usana Health Sciences, have provided updates to their cases.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10